Macleods Pharmaceuticals has secured approval from the U.S. Food and Drug Administration for ANDA 210944, a development expected to significantly expand its manufacturing capacity and strengthen its footprint in the generic market. This regulatory clearance is anticipated to drive revenue contributions as the product ramps up into full commercial rollout.